| Open Document File Size: 65,31 KBShare Result on Facebook
City Waunakee / / Company Chicago Tribune / Heparin / Baxter Healthcare Corporation / Washington Post / American Pharmaceutical Partners / CNN / / Country United States / China / / Event Person Travel / / Facility New Jersey facility / Changzhou SPL facility / / IndustryTerm manufacturing practice inspection / manufacturing window / pharmaceutical ingredients / drug manufacturing technology / abbreviated new drug applications / manufacturing practice requirements / credential media / manufacturing / active pharmaceutical ingredients / pharmaceutical industries / active pharmaceutical ingredient manufacturer / manufactured finished products / manufacturing process / / Organization CDER office of Compliance / CEDER office of Compliance / Center for Drugs / U.S. Food and Drug Administration / FDA’s office of Regulatory Affairs / / Person Karen Riley Monday / Karen Riley / Cherry Hill / Michael Rogers / Joe Famulare / Grassley / Bruce Japsen / Marc Kaufman / Miriam Falco / David Greising / / Position EST Coordinator / Coordinator / Deputy Director / Conference coordinator / Director of the Division of Field Investigations / chemist / / ProvinceOrState New Jersey / Wisconsin / Iowa / / PublishedMedium the Chicago Tribune / Washington Post / / Technology drug manufacturing technology / API / /
SocialTag |
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may